Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Bone-strengthening drugs for cancer are now available. They can help treat cancer that has spread to the bones (bone ...

In general, IV bisphosphonates are very well tolerated ... adverse events in both treatment groups were mild to moderate bone pain, nausea, fatigue, and fever ( Table 2). [14] Less than 5% ...

Discontinuation of bisphosphonate therapy correlated with ... translate to other populations of patients with cancer and metastatic bone disease? According to Cesar Migliorati, Professor of ...